The global market for digital pathology is estimated to reach US$ 6,199 Million by 2022, according to Future Market Insights. The market for digital pathology goods and services is expected to reach US$ 22,870.2 Million by 2032, increasing at a 13.5% CAGR during the forecast period.
Digital pathology solutions are getting more popular in the market as a result of technical advancements and the expansion of electronic medical records in the healthcare industry. Cloud-based information systems are predicted to grow at a 16.9% CAGR through 2032, while on-premise systems will continue to dominate at $626.8 Million.
One of the most commonly used words in modern pathology is digital pathology, sometimes known as virtual microscopy. Digital pathology, often known as 'virtual microscopy,' is an image-based system that allows pathology data to be obtained, maintained, and interpreted using digitised glass slides. The use of digital pathology in the treatment of chronic and infectious diseases such as cancer, cardiovascular disease, and hepatitis is becoming more widespread.
In the market, there has been a boom in projects targeted at promoting affordable digital pathology solutions. The worldwide digital pathology market is predicted to rise significantly during the forecast period as a result of more teleconsultations. Digital pathology, as a developing technology, is assisting in human pathology practise, medication discovery, and tissue-based research in the medical industry.
Over the projected period, North America is expected to have the greatest global digital pathology market share. The United States has the greatest proportion of the region's increasing cancer prevalence and expanding demand for better diagnostics. Over the projection period, government initiatives and favourable reimbursement policies will drive the growth of the digital pathology market in the United States.
Key Players in the Digital Pathology Market:
- Danaher Corporation
- F. Hoffmann-La Roche AG
- Huron Technologies International Inc.
- Koninklijke Philips N.V.
- Olympus Corporation
- Hamamatsu Photonics K.K.
- Carl Zeiss AG
- Nikon Corporation
- 3DHISTECH Ltd.
- Hologic Inc.
- PerkinElmer, Inc.
- Visiopharm
- OptraSCAN, Inc.
- Inspirata, Inc.
- Sectra AB
Get More Details@ https://www.futuremarketinsights.com/reports/Global-digital-pathology-market
Key Segments Profiled in the Global Digital Pathology Market
Digital Pathology by Product Type:
- Digital Pathology Equipment
- Whole Slide Scanners
- Brightfield Slide Scanners
- Fluorescence Slide Scanners
- Combination Slide Scanners
- Clinical Microscope
- Tissue Microarrays
- Digital Pathology Software
- Image Viewing and Analysis Software
- On-premise
- Cloud-based
- Digital Pathology Information Systems
- On-premise
- Cloud-based
- Digital Pathology Services
- Installation and Integration Services
- Consulting Services
- Maintenance and Validation Services
Digital Pathology by Application:
- Clinical Pathology
- Molecular Diagnostics
- Basic & Applied Research
- Drug Development
- Others
Digital Pathology by End User:
- Hospitals
- Diagnostic Laboratories
- Pharmaceutical & Biotechnology Companies
- Forensic Laboratories
- Research Institutes
- Contract Research Organizations (CROs)
- Clinics
